IMC Chicago’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Buy
22,400
+2,300
+11% +$204K ﹤0.01% 2528
2025
Q4
$1.61M Sell
20,100
-2,800
-12% -$234K ﹤0.01% 2592
2025
Q3
$2.24M Sell
22,900
-10,900
-32% -$878K ﹤0.01% 2143
2025
Q2
$2.36M Buy
33,800
+7,500
+29% +$428K ﹤0.01% 1890
2025
Q1
$1.31M Sell
26,300
-7,000
-21% -$443K ﹤0.01% 2092
2024
Q4
$2.33M Buy
33,300
+12,500
+60% +$1.04M ﹤0.01% 1750
2024
Q3
$2.18M Sell
20,800
-7,900
-28% -$924K ﹤0.01% 1606
2024
Q2
$4.08M Buy
28,700
+2,800
+11% +$323K ﹤0.01% 1159
2024
Q1
$2.89M Buy
+25,900
New +$3.09M ﹤0.01% 1188

Other funds holding ACLS

IMC Chicago's ACLS Position: Q1 2026 in Review

IMC Chicago opened a new position in Axcelis (ACLS) in Q1 2026: 6,736 shares worth $627K. The stake represents ﹤0.01% of the portfolio and ranks #3782 among its holdings. This is a return to the name: IMC Chicago previously reported a position in ACLS as recently as Q1 2025.

IMC Chicago first reported a position in ACLS in Q1 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • IMC Chicago held 6,736 shares of Axcelis worth $627K as of Q1 2026.
  • Axcelis was a new IMC Chicago position in Q1 2026.
  • Axcelis made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3782 holding.
  • IMC Chicago first reported a position in Axcelis in Q1 2025 and has held it in 2 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.